Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy

Author： Banna Giuseppe Luigi Aversa Savina Maria Luciana Cattelan Anna Maria Crivellari Gino Monfardini Silvio

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.36, Iss.2, 2004-02, pp. : 155-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 551-557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics of respiratory syncytial virus‐related apnoea in three infants

ACTA PAEDIATRICA, Vol. 93, Iss. 6, 2004-06 ,pp. : 847-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

Late‐onset Epstein–Barr virus‐related disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation is associated with impaired early recovery of T and B lymphocytes

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 902-0063, Iss. 10, 2015-10 ,pp. : 904-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 10, 2015-10 ,pp. : 904-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32––35 weeks: a Canadian-based analysis**

By Lanctôôt Krista L. Masoud Shababa T. Paes Bosco A. Tarride Jean-Eric Chiu Aaron Hui Charles Francis Philip L. Oh Paul I.

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3223-3237

Informa Healthcare

Access to resources Recommend Favorite